Drug transporter inhibition risk
transporter_inhibition_risk.RdDrug transporter inhibition risk
Usage
transporter_inhibition_risk(
perp,
transporter_inh,
transporter_ref = transporter_reference_data,
qh = 1.616
)Details
The metric for the assessment of transporter interactions is \(R=[I]/IC_{50}\).
The relevant precipitant concentrations \([I]\) and regulatory thresholds of concern are:
| I | transporter | threshold |
| \(I_{gut}\) | P-gp and BRCR when drugs are orally administered | 10 |
| \(C_{max,ss,u}\) | P-gp and BRCR when drugs are administered parenterally or for drug metabolites | 0.02 |
| \(I_{max,inlet,u}\) | hepatic basolateral transporters OCT1, OATP1B1 and OATP1B3 | 0.1 |
| \(C_{max,ss,u}\) | renal basolateral transporters OAT1, OAT3 and OCT2 | 0.1 |
| \(C_{max,ss,u}\) | apical transporters MATE1 and MATE2-K | 0.02 |
Examples
transporter_inhibition_risk(examplinib, examplinib_transporter_inhibition)
#> ──────── Clinical DDI risk assessment ────────
#> Transporter inhibition risk for examplinib
#>
#> object ic50 source i r threshold risk
#> Pgp_int 0.41 study 005 igut 8910 10 TRUE
#> Pgp_sys 0.41 study 005 imaxssu 0.402 0.02 TRUE
#> BCRP_int 1.9 study 005 igut 1920 10 TRUE
#> BCRP_sys 1.9 study 005 imaxssu 0.0867 0.02 TRUE
#> OATP1B1 177 study 006 imaxinletu 0.00109 0.1 FALSE
#> OATP1B3 35 study 006 imaxinletu 0.00551 0.1 FALSE
#> OAT1 271 NA imaxssu 0.000608 0.1 FALSE
#> OAT3 300 NA imaxssu 0.000549 0.1 FALSE
#> BSEP 12.8 NA imaxssu 0.0129 0.1 FALSE
#> OCT1 2.3 study 006 imaxssu 0.0717 0.1 FALSE
#> OCT2 67 study 006 imaxssu 0.00246 0.1 FALSE
#> MATE1 3.6 study 006 imaxssu 0.0458 0.02 TRUE
#> MATE2k 1.1 study 006 imaxssu 0.15 0.02 TRUE